Respiratory syncytial virus (RSV) immunisation RSV prevention resources and data to assist healthcare providers and the general public NCIRS' RSV resources are currently undergoing technical review and will be updated soon. RSV – frequently asked questions (FAQs) RSV immunisation products – evaluation and expected access RSV immunisation products – efficacy and safety NCIRS webinar: RSV and older adults NCIRS webinar: RSV and infants RSV vaccine safety data – AusVaxSafety Useful linksAustralian Immunisation Handbook RSV chapter – Australian Government Department of Health and Aged CareATAGI statement on the clinical use of Arexvy (RSV PRE-F3) vaccine for RSV – Australian Government Department of Health and Aged CareArexvy: Australian prescription medicine decision summary – TGABeyfortus: Australian prescription medicine decision summary – TGABeyfortus (nirsevimab) guidance:NSW HealthQueensland HealthWA HealthRSV clinical trial tracker – PATHRSV vaccine safety data – AusVaxSafety News & events News | 16 December 2024 Vaccination rates among Australian teens are dropping. Here’s how we can get back on track News | 03 December 2024 New findings link access and acceptance barriers with partial childhood vaccination News | 15 November 2024 Gavi CEO injects new level of support for Pacific Island nations News | 08 November 2024 Expressions of interest now open: join NCIRS’ Aboriginal and Torres Strait Islander Reference Group 2273 views